Status:
COMPLETED
Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Vasomotor Symptoms
Eligibility:
FEMALE
20-55 years
Phase:
PHASE1
Brief Summary
Safety, tolerability, and pharmacokinetics (PK) of desvenlafaxine succinate sustained release (DVS SR) in healthy Japanese female subjects.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy, first-generation (born in Japan, living in the US for less than 5 years)
- Japanese female subjects
Exclusion
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00397176
Start Date
November 1 2006
End Date
February 1 2007
Last Update
December 28 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.